Travis Drow

Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models

P. Linsley, D. Liggitt, D. Rawlings, 2022, Science Translational Medicine.

A Chemically Inducible IL-2 Receptor Signaling Complex Allows for Effective In Vitro and In Vivo selection of Engineered CD4+ T cells.

A. Scharenberg, D. Rawlings, Annaiz M. Grimm, 2023, Molecular therapy : the journal of the American Society of Gene Therapy.